Abstract:Abstract PU.1 (Sfpi1) is an ets family transcription factor required for the proper generation of both myeloid (macrophages and neutrophils) and lymphoid lineages (B and T lymphocytes)(Scott 1994, McKercher 1996). Graded expression of exogenous PU.1 in murine PU.1-deficient fetal liver hematopoietic progenitors demonstrated that increased levels of PU.1 are required to initiate development of macrophages (DeKoter, 2000). We have studied the effects of graded expression of PU.1 on its occupancy in chromatin and on the development of myeloid cells in vitro. We measured changes in gene expression, PU.1 occupancy and histone modifications in PU.1-null hematopoietic progenitor cells stably expressing PU.1 fused to the ligand-binding domain of the estrogen receptor (PU.1-ER) (Walsh 2002). The level of active PU.1-ER was regulated with graded levels of the ER inducer tamoxifen. In vitro, intermediate levels of tamoxifen produced cells with granulocyte characteristics in the suspension cell fraction and macrophage-like characteristics in the attached fraction, whereas high levels of PU.1 produced mostly attached macrophage-like cells. Expression of granulocyte-specific PU.1 target mRNAs including gelatinase B (Mmp9) and myeloperoxidase (Mpo) were observed to be expressed only with intermediate levels of tamoxifen. In contrast, expression of macrophage PU.1 target mRNAs including Cd14, F4/80 and Cd68 mRNAs were observed to be gradually upregulated upon PU.1-ER activation, with the maximum expression at the highest levels of tamoxifen. Thus, the expression levels of PU.1 target genes and phenotypic characteristics of the cells are dependent on PU.1 levels. Interestingly, macrophage-like cells can be produced from granulocytic-like cells by changing tamoxifen levels and vice versa. Chromatin immunoprecipitation analysis revealed specific PU.1 occupancy within regulatory regions of the genes predominantly expressed in macrophages including Cd14 and Cd11b after treatment with high levels of tamoxifen. Specific PU.1 occupancy within regulatory regions of the granulocyte specific genes including MMP9 was observed at intermediate levels of tamoxifen. Suprisingly, chromatin immunoprecipitation analysis revealed specific PU.1 occupancy within regulatory regions of the lymphocytic PU.1 target genes including Interleukin-7 receptor (Il-7r) and RAG1 at intermediate levels of tamoxifen even though expression of these genes was not detected. Accumulation of acetylated K9 and methylated K4 of histone H3 in gene loci of macrophage and granulocytic markers such as Cd14, Cd11b, and Mmp9 correlated with their mRNA expression. However, lymphocyte-specific regulatory regions including that of Il-7r gene were hypoacetylated in H3K9 despite a marked PU.1 recruitment suggesting additional factors may be required for PU.1 mediated transactivation. To identify these molecules we have tested PU.1-dependent transcription factors: Egr2, Nab2, Cebpa and Gfi-1 and found that upon increasing PU.1 levels, expression of Egr2/Nab2 and Gfi-1/Cebpa changed in a reciprocal manner and these changes preceded expression of the lineage specific markers. We are currently testing if PU.1 directly regulates expression of Egr2, Nab2, Cebpa and Gfi-1 during granulocytic/macrophage differentiation.

PU.1 and C/EBPα/β convert fibroblasts into macrophage-like cells

PU.1 Dose-Dependently Induces Granulocyte or Macrophage Commitment by Targeting Lineage Restricted Genes and by Regulating Transcription Factors Egr2, Nab2, Cebpa and Gfi1.

Supplemental Data Stepwise Reprogramming of B Cells into Macrophages

Reprogramming of Committed T Cell Progenitors to Macrophages and Dendritic Cells by C/Ebp Alpha and Pu.1 Transcription Factors

T To Myeloid Lineage Reprogramming By The Synergistic Action Of C/Ebp And Pu.1.

Carm1-arginine methylation of the transcription factor C/EBPα regulates transdifferentiation velocity

Dermatopontin-expressing fibroblasts mediate an essential skin macrophage niche

Identification of three genes up-regulated in PU.1 rescued monocytic precursor cells

Attenuation of PRRX2 and HEY2 Enables Efficient Conversion of Adult Human Skin Fibroblasts to Neurons.

The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1β eRNA and mRNA transcription in mouse melanoma and macrophage cell lines

Endothelial Forkhead Box Transcription Factor P1 Regulates Pathological Cardiac Remodeling Through Transforming Growth Factor-β1–Endothelin-1 Signal Pathway

Krüppel Like Factor 4 Promoter Undergoes Active Demethylation During Monocyte/Macrophage Differentiation

Cxxc Finger Protein 1 Positively Regulates Gm-Csf-Derived Macrophage Phagocytosis Through Csf2r Alpha-Mediated Signaling

Functional PU.1 in Macrophages Has a Pivotal Role in NF-κB Activation and Neutrophilic Lung Inflammation During Endotoxemia

Progress of PU.1-regulated Adipogenesis in Preadipocytes

Mechanisms of Action of Hematopoietic Transcription Factor PU.1 in Initiation of T-Cell Development

C/EBPalpha directs monocytic commitment of primary myeloid progenitors

Dynamic Regulation of PU.1 Expression in Multipotent Hematopoietic Progenitors

Fibroblast transdifferentiation promotes conversion of M1 macrophages and replenishment of cardiac resident macrophages following cardiac injury in mice

Targeted regulation of fibroblast state by CRISPR-mediated CEBPA expression

The alternative polyadenylation regulator CFIm25 promotes macrophage differentiation and activates the NF-κβ pathway